- Our Services
-
Patients and Families
- Get Directions
- Parking
- Childrens Locations
- Getting Around
- Guidelines for Visitors
- Contact a Patient
- Contact Children's
- Send an e-Card
- Gift Shop
Planning a Visit
- Find a Doctor
- Child Health A-Z
- Community Ed.Classes
- Injury Prevention
- International Patients
- Medical Records
- Patient Handbook
- Patient Procedures
Parents
- For Health Professionals
- Research
- Ways to Give
-
News
-
Adding Breast Milk Ingredient to Formula Could Prevent Deadly Intestinal Problem in Premature Babies
-
Children's Holds Groundbreaking Ceremony for Expansion to New South Fayette Location
-
Child Neurodevelopmental and Mental Health Disabilities on the Rise, Study Finds
News Releases
-
Research
Retinoblastoma Genetic Analysis
Carcinogen Metabolism, DNA Repair, Parental Exposures and Retinoblastoma
Protocol Description
The main goal of this Children’s Oncology Group observational study is to understand how genes and environmental exposures affect a child’s chances of developing retinoblastoma, a cancer of the eye. To do this researchers will compare the exposures and genes of children with unilateral (one eye) or bilateral (both eyes) retinoblastoma to that of children who do not have retinoblastoma.
Eligibility Criteria
Subject to certain exclusion criteria, children of both genders who have been diagnosed with sporadic retinoblastoma on or after 07/01/2006.
Males: All ages
Females: All ages
Requirements
Researchers will conduct a telephone interview about health and medical history with parents and collect blood or saliva samples from both the child and parents. Alternately, saliva samples may be collected. If the child had or will have surgery to remove the tumor and there is leftover tissue from surgery, researchers will analyze the tumor DNA for certain gene mutations.
Visits: Not applicable
Duration: Genetic analysis may take up to 1 year, but can be shared with the participant’s physician, if desired by the parents.
Status: Open for Enrollment
Source(s) of Support
Children’s Oncology Group (Study AEPI05N1)
National Cancer Institute
Additional Resources
Study Description at National Institutes of Health
Primary Investigator(s)
A. Kim Ritchey, MD
Contact Information
For additional information, please contact:Jill Visnich412-692-5964
Last Update
October 30, 2010
October 30, 2010
